The Mylan EpiPen debacle may have inadvertently weakened the grip Big Pharma on U.S. lawmakers. Last week, a bill proposed by Senator Bernie Sanders was narrowly rejected by a vote of 52-46. Unexpectedly, 12 Republicans and 1 Independent voted with Senator Sanders in favor of allowing pharmacists and distributors to import cheaper prescription drugs from Canada and other foreign countries (something typically favored by Democrats.) The winds of change are starting to blow in the bipartisan direction when it comes to the pharmaceutical industry.
U.S. Healthcare needs a revolution ; ‘the shot heard round the world’ often refers to the opening shots of the American Revolution in 1775. The Big Pharma lobby is holding the American people hostage with their exorbitant ransom demands. Last summer, Mylan Pharmaceuticals, led by CEO Heather Bresch, overplayed their hand. Mylan came under fire for a 400% price increase in the EpiPen two-pack. This device is considered life-saving for children and adults with anaphylactic reactions to various food, insect, or environmental insults. Ms. Bresch insisted the significant price increase ($600-$700 for a medication which costs pennies) was justified due to the more ergonomic appearance of the delivery device and improved safety profile. Her miscalculation seems to have indirectly incited the war on Big Pharma by angering the public, the media, and the government simultaneously.